Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America, et. al., ex. rel. Alex Booker, et. al. v. Pfizer, Inc.
Case Number:
1:10-cv-11166
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
May 24, 2016
Pfizer Beats FCA Suit Over Geodon Marketing
A Massachusetts federal judge handed Pfizer a sweeping victory Monday by tossing all the remaining False Claims Act allegations in a suit over the marketing of antipsychotic Geodon.
-
March 26, 2014
Pfizer Fails To Get Geodon Off-Label Use Case Tossed
A Massachusetts federal judge on Wednesday refused to throw out a False Claims Act whistleblower suit alleging Pfizer Inc. improperly promoted off-label use of schizophrenia drug Geodon, instead trimming the suit by limiting the scope of a few claims.
-
January 16, 2013
Pfizer Says Off-Label Marketing FCA Suit Falls Short
Pfizer Inc. asked a Massachusetts federal court on Tuesday to dismiss a False Claims Act whistleblower suit alleging that it improperly promoted off-label use of a schizophrenia drug, saying that the plaintiffs have failed to show that the drugmaker actually defrauded federal health care programs.